Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...
The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
Diane Lacroix, Vice President of Clinical Data Management at eClinical Solutions, talks personalised medicine, data decisions ...
As the capabilities of generative AI models have grown, you've probably seen how they can transform simple text prompts into ...
In an effort to boost growth, the UK government plans to “unleash AI” and has invested £225 million (~US $275 million) in ...
Tempus AI announces the launch of olivia, an AI-enabled personal health concierge app designed to revolutionize patient care ...
Tripura Chief Minister Manik Saha launched the state's first drug de-addiction centre in Sepahijala. The facility, costing Rs ...